Information Request Form

Section:	Main.ENDOCRINOLOGY.Diabetes. Treatment.Biguanide. SulfonylUrea. Combi..BuFormin.Salt+Glibenclamide Tablet.Patent..Claims.Claim 15: Controlled Release Tablet.a) Core, i) BuFormin or Salt; ii).Glyburide; iii) PolyVinyl Pyrrolido.ne & iv) Na Lauryl Sulfate; b).Optional Seal Coat; c).SemiPermeable Membrane Coating.i) Cellulose Acetate; ii).PolyEthylene Glycol; MW=380-420..& iii) Plasticizer & d) Passageway.in (c) Claim 28:Absorption Enhancer.Select: Fatty Acid, Chelant Etc..Claim 29: Capric Acid Etc. Claim 30.: Chelant Select: Citric Acid Etc..Claim 31: Absorption Enhancer: Bile.Salt. Claim 33: Flux Enhancer..Claim 34: Flux Enhancer: NaCl; PEG.Claim 35: Flux Enhancer:.PolyEthylene Glycol; MW=380-420..Claim 37: (c) has 2 Passageways.Patent Assignee
Code:	61291
Product:	USA. A
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER PATENT PARENT CASE TEXT
* If you are not linked to any company or organization complete at least this field